Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies

Conditions: Multiple Sclerosis

Interventions: Other: Ofatumumab

Sponsors: Novartis Pharmaceuticals

Active, not recruiting

Clinical Trials online